Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ORAL COMPOSITE TABLET COMPRISING EZETIMIBE AND ROSUVASTATIN
Document Type and Number:
WIPO Patent Application WO/2018/101681
Kind Code:
A1
Abstract:
An oral composite tablet and a method of preparing the same are provided. The oral composite tablet includes: an ezetimibe wet granule portion including ezetimibe; and a rosuvastatin mixture portion including rosuvastatin or a pharmaceutically acceptable salt thereof, wherein the ezetimibe wet granule portion includes, as a binder, povidone having a weight average molecular weight of about 30,000 to about 50,000, and the rosuvastatin mixture portion includes a diluents including a water-soluble diluent and a water-insoluble diluent, the water-insoluble diluent having a particle size (d90) of about 98 μm to about 229 μm corresponding to 90% in a cumulative particles size distribution of total particles.

Inventors:
SONG HAN BYUL (KR)
CHO JUNG HYUN (KR)
KIM JIN CHEUL (KR)
KIM YOUG IL (KR)
PARK JAE HYUN (KR)
WOO JONG SOO (KR)
Application Number:
PCT/KR2017/013508
Publication Date:
June 07, 2018
Filing Date:
November 24, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HANMI PHARM IND CO LTD (KR)
International Classes:
A61K9/20; A61K31/397; A61K31/505
Domestic Patent References:
WO2009024889A22009-02-26
Foreign References:
KR20160000762A2016-01-05
KR20150079454A2015-07-08
KR20160105044A2016-09-06
US20140287042A12014-09-25
Attorney, Agent or Firm:
Y.P.LEE, MOCK & PARTNERS (KR)
Download PDF: